Article thumbnail

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer

By J Van den Brande, P Schöffski, J H M Schellens, A D Roth, F Duffaud, K Weigang-Köhler, F Reinke, J Wanders, R F de Boer, J B Vermorken and P Fumoleau
Topics: Clinical
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:2376342
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1998). An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)]. Gan To Kagaku Ryoho 25: 1035–1043 Tatsumi
  2. (2000). Cancer of the colon. In Cancer: Principles and Practice of Oncology on
  3. (1998). Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)]. Gan To Kagaku Ryoho 25:
  4. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18: 2938–2947 DeMario MD, Ratain MJ
  5. (1999). Phase I and pharmacokinetic (PK) study of the novel oral fluoropyrimidine, S-1. Proc Annu Meet Am Soc Clin Oncol 18: A665 Hoff
  6. (1997). Phase I study of S-1. S-1
  7. (1994). Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344: 1255–1260